scinapse is loading now...
Ahmet Alacacioglu
Izmir Kâtip Çelebi University
139Publications
16H-index
839Citations
Publications 139
Newest
Published on Apr 1, 2018in Journal of Oncological Sciences
Ibrahim Yildiz1
Estimated H-index: 1
(Acıbadem University),
Halil Taşkaynatan1
Estimated H-index: 1
(Izmir Kâtip Çelebi University)
+ 6 AuthorsMustafa Oktay Tarhan11
Estimated H-index: 11
(Dokuz Eylül University)
Abstract Introduction The use of FOLFOXIRI (oxaliplatin, irinotecan, leucovorin, and 5-fluorouracil) as first-line therapy for metastatic colorectal cancer (mCRC) is well-established. However, there is no data about the effectiveness of this regimen in pretreated patients in the current literature. In this case report, we aim to evaluate the efficacy and benefit of FOLFOXIRI in patients who received standard regimens. Case report 3 patients were treated with FOLFOXIRI and 1 patient received FOLF...
Source Cite
Published on Oct 1, 2018in Journal of Laboratory Physicians
Serife Medeni Solmaz1
Estimated H-index: 1
,
Ozcan Uzun + 8 AuthorsMehmet Ali Özcan13
Estimated H-index: 13
(Dokuz Eylül University)
BACKGROUND: Recent reports showed neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR), as a predictor of progression-free survival (PFS) and overall survival (OS) in various malignancies. MATERIALS AND METHODS: We retrospectively examined the PLR, NLR, and MLR in a cohort of 186 newly diagnosed multiple myeloma (MM) patients. This study investigated the prognostic relevance of NLR, PLR, and MLR in MM patients. NLR, PLR, and MLR were ca...
Source Cite
Published on Jan 1, 2018in Polish Journal of Pathology 0.86
Betul Bolat Kucukzeybek3
Estimated H-index: 3
,
Ibrahim Vedat Bayoglu6
Estimated H-index: 6
+ 7 AuthorsMustafa Oktay Tarhan11
Estimated H-index: 11
Source Cite
Published on Oct 4, 2018in Open Medicine 0.48
Halil Taşkaynatan1
Estimated H-index: 1
,
Ahmet Alacacioglu16
Estimated H-index: 16
+ 5 AuthorsMustafa Oktay Tarhan11
Estimated H-index: 11
Source Cite
Published on Oct 1, 2018in Annals of Oncology 13.93
Utku Oflazoglu1
Estimated H-index: 1
(Izmir Kâtip Çelebi University),
Umut Varol9
Estimated H-index: 9
(Izmir Kâtip Çelebi University)
+ 7 AuthorsMustafa Oktay Tarhan11
Estimated H-index: 11
(Dokuz Eylül University)
Source Cite
Published on Oct 1, 2018in Annals of Oncology 13.93
Ahmet Alacacioglu16
Estimated H-index: 16
(Izmir Kâtip Çelebi University),
Gülçin Dişsiz1
Estimated H-index: 1
(Izmir Kâtip Çelebi University)
+ 2 AuthorsN Asik (Izmir Kâtip Çelebi University)
Source Cite
Published on Oct 1, 2018in Annals of Oncology 13.93
Ece Esin (University of Health Sciences Antigua), O B Cakmak Oksuzoglu + 17 AuthorsSemra Paydas22
Estimated H-index: 22
(Çukurova University)
Source Cite
12345678910